Crinetics Pharmaceuticals, Inc. (CRNX)
43.84
+0.40
(+0.92%)
USD |
NASDAQ |
Feb 23, 16:00
43.84
0.00 (0.00%)
After-Hours: 19:28
Crinetics Pharmaceuticals SG&A Expense (Quarterly) : 52.26M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Madrigal Pharmaceuticals, Inc. | 239.98M |
| GT Biopharma, Inc. | 2.748M |
| Axsome Therapeutics, Inc. | 150.24M |
| Sutro Biopharma, Inc. | 8.741M |
| Gossamer Bio, Inc. | 9.39M |